Drug Distributor Cardinal Seeks More China Acquisitions
This article was originally published in PharmAsia News
Executive Summary
China is a major target for more acquisitions by U.S. drug distributor Cardinal Health, well beyond its purchase of Zuellig Pharma China for $60 million last year